Sartorius AG
XETRA: SRT3.DE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Deutsche Börse
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Michael Grosse
- Employees
- 13,573
- Headquarters
- Göttingen, Germany
- IPO year
- 1999
- Market cap
- €15.0B
- Website
- https://www.sartorius.com
Loading SRT3…
Loading profile data…Frequently asked questions about SRT3
What does Sartorius AG (SRT3.DE) do?
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinan...
Where does SRT3.DE trade?
Sartorius AG (SRT3.DE) trades on the Deutsche Börse.
What sector is SRT3.DE in?
Sartorius AG (SRT3.DE) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Sartorius AG?
Michael Grosse is the chief executive officer of Sartorius AG (SRT3.DE).
Where is Sartorius AG headquartered?
Sartorius AG is headquartered in Germany.
Does SRT3.DE pay a dividend?
Yes — Sartorius AG (SRT3.DE) paid a trailing twelve-month dividend of EUR 0.74 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did SRT3.DE go public?
Sartorius AG (SRT3.DE) completed its initial public offering in 1999.